CARDIOTOXIC EFFECTS OF BTK INHIBITORS : PHARMACOVIGILANCE ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE

被引：0
|
作者：
Patel, Sagar [1 ]
Pandya, Krutarth K. K. [1 ]
Raval, Maharshi [1 ]
Patel, Akanksha [1 ]
Trivedi, Jaahnavee [1 ]
Patel, Riya [1 ]
Titus, Anoop [1 ]
Sattar, Yasar [1 ]
Victor, Varun [1 ]
Alraies, M. Chadi [1 ]
Bhakta, Shyam [1 ]
机构：
[1] Landmark Med Ctr, Woonsocket, RI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1744-044
引用
收藏
页码：2390 / 2390
页数：1
相关论文
共 50 条
  • [1] Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Sun, Ximu
    Zhou, Han
    Li, Yanming
    Luo, Yanhui
    Guo, Qixiang
    Sun, Yixin
    Jia, Chenguang
    Wang, Bin
    Qin, Maoquan
    Guo, Peng
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 11 (01)
  • [2] Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
    Liu, Ruixue
    Liu, Chunxiao
    Feng, Dianwei
    Guo, Tongxin
    Wang, Ying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [4] Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhou, Chaozheng
    Peng, Shengkun
    Lin, Anqi
    Jiang, Aimin
    Peng, Yuanxi
    Gu, Tianqi
    Liu, Zaoqu
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    ECLINICALMEDICINE, 2023, 59
  • [5] Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Ma, Zhuo
    Pei, Jie
    Sun, Ximu
    Liu, Lihong
    Lu, Wenchao
    Guo, Qixiang
    Lyu, Jiayou
    Liu, Yuwei
    Zhang, Yuhui
    Zhao, Zhixia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database
    Chen, Jinhua
    Tang, Linlin
    Song, Wenping
    Sun, Cuicui
    Zhang, Wenzhou
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Psychiatric disorders associated with fluoroquinolones: a pharmacovigilance analysis of the FDA adverse event reporting system database
    Xie, Wen-Long
    Ge, Meng-Lan
    Chen, Dan
    Chen, Guo-Qing
    Mei, Yuan-Xi
    Lai, Yong-Ji
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [8] Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
    Zhou, Jianxing
    Wei, Zipeng
    Xu, Baohua
    Liu, Maobai
    Xu, Ruichao
    Wu, Xuemei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
    Wu, Yan
    Wei, Meihao
    Zhang, Jing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Biliary toxicity of immune checkpoint inhibitors: A pharmacovigilance study through FDA adverse event reporting system database
    Guo, Qixiang
    Lu, Wenchao
    Wang, Tiansheng
    Zhao, Zhixia
    Liu, Lihong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 157 - 157
12345